A detailed history of Corient Capital Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,448 shares of VRTX stock, worth $2.52 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,448
Previous 5,323 2.35%
Holding current value
$2.52 Million
Previous $1.5 Million 2.33%
% of portfolio
0.11%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $34,228 - $38,191
125 Added 2.35%
5,448 $1.54 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $163,297 - $203,322
695 Added 15.02%
5,323 $1.5 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $170,271 - $200,685
769 Added 19.93%
4,628 $1.21 Million
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $122,844 - $155,074
694 Added 21.93%
3,859 $848,000
Q3 2021

Nov 16, 2021

SELL
$181.39 - $202.99 $83,802 - $93,781
-462 Reduced 12.74%
3,165 $574,000
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $35,810 - $42,230
191 Added 5.56%
3,627 $732,000
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $29,396 - $34,266
142 Added 4.31%
3,436 $738,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $50,096 - $66,813
242 Added 7.93%
3,294 $779,000
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $58,032 - $68,803
-227 Reduced 6.92%
3,052 $830,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $58,173 - $76,316
258 Added 8.54%
3,279 $952,000
Q1 2020

May 06, 2020

BUY
$199.77 - $247.81 $71,517 - $88,715
358 Added 13.44%
3,021 $719,000
Q4 2019

Feb 04, 2020

BUY
$166.71 - $223.91 $10,502 - $14,106
63 Added 2.42%
2,663 $583,000
Q3 2019

Nov 06, 2019

BUY
$166.23 - $187.09 $90,096 - $101,402
542 Added 26.34%
2,600 $441,000
Q2 2019

Aug 08, 2019

SELL
$164.61 - $190.37 $98,930 - $114,412
-601 Reduced 22.6%
2,058 $377,000
Q1 2019

May 10, 2019

BUY
$163.73 - $194.7 $206,299 - $245,322
1,260 Added 90.06%
2,659 $489,000
Q4 2018

Feb 07, 2019

BUY
$151.91 - $192.21 $212,522 - $268,901
1,399 New
1,399 $232,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.